New study: can a biologic drug help diverse patients breathe better and smell again?

NCT ID NCT05246267

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether adding dupilumab to standard steroid nasal sprays improves symptoms and sense of smell in people with chronic sinusitis and nasal polyps. It focuses on a diverse, mostly minority group of 60 adults. Participants will receive dupilumab injections and be monitored for changes in symptom scores and smell tests.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Dupilumab (a biologic drug given as an injection)

What this could lead to

If successful, this could show that dupilumab works well for nasal polyps in a diverse, mostly minority population, helping to reduce symptoms and improve quality of life.

What could go wrong

This is a small, early-stage study with only 60 participants, so results may not apply to everyone. Dupilumab can cause side effects like injection site reactions and allergic reactions.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC RHINOSINUSITIS WITH NASAL POLYPS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Montefiore Medical Center

    RECRUITING

    The Bronx, New York, 10461, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact